Literature DB >> 23623891

Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.

Patrick St-Pierre1, Alain Deschamps1, Raymond Cartier2, Arsène J Basmadjian3, André Y Denault4.   

Abstract

Entities:  

Keywords:  brain oxygenation; inhaled epoprostenol; inhaled milrinone; left atrial myxoma; pulmonary hypertension; right ventricular failure

Mesh：

Substances：

Year:  2013        PMID： 23623891     DOI： 10.1053/j.jvca.2012.10.017

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  3 in total

1.  A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.

Authors:  André Y Denault; Jean S Bussières; Ramiro Arellano; Barry Finegan; Paul Gavra; François Haddad; Anne Q N Nguyen; France Varin; Annik Fortier; Sylvie Levesque; Yanfen Shi; Mahsa Elmi-Sarabi; Jean-Claude Tardif; Louis P Perrault; Jean Lambert
Journal:  Can J Anaesth       Date:  2016-07-28       Impact factor: 6.713

Review 2.  Inhaled therapy for the management of perioperative pulmonary hypertension.

Authors:  C A Thunberg; S T Morozowich; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2015 Jul-Sep

3.  Does Inhaled Milrinone Facilitate Weaning From Cardiopulmonary Bypass in Children with Congenital Heart Diseases Complicated with Pulmonary Arterial Hypertension?

Authors:  Ibrahim Ibrahim Abd Elbaser; Ahmad Abd El Aleem El Derie
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.